Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation

Not Applicable

Terminated

• Conditions: Chronic, Non-neuropathic Back Pain
• Interventions: Behavioral: Support Group; Behavioral: Mindfulness-Oriented Recovery Enhancement (MORE)

• Registration Number: NCT02935465
• Lead Sponsor: University of Utah

Brief Summary

The overarching aim of this project is to conduct a randomized controlled study to determine whether Mindfulness-Oriented Recovery Enhancement (MORE) vs. a Support Group (SG) can improve pain regulation and hedonic functions (i.e., natural reward responsiveness) thought to be governed by the endogenous opioid system among opioid-treated, chronic, non-neuropathic back pain patients (CNBP) and thereby improve clinical pain, affect, and opioid use.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09
• Study First Submitted: 2016-10-11
• Study First Submitted QC: 2016-10-13
• Study First Posted: 2016-10-17
• Primary Completion: 2019-06
• Study Completion: 2019-06
• Status Verified: 2020-03
• Last Update Submitted: 2020-03-04
• Last Update Posted: 2020-03-06

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

1. age 21-60 years of age
2. English fluency
3. 20/20 vision with corrective lenses
4. current chronic, non-neuropathic back pain diagnosis determined by physician assessment
5. reporting pain ≥3 on 0-10 scale with opioid medication
6. current use of prescription opioids for ≥3 consecutive months
7. ability to understand study procedures and to comply with them for the entire length of the study

Read More

Exclusion Criteria

1. Mindfulness experience (e.g., MBSR or shamatha/vipassana meditation)
2. psychosis
3. untreated, active suicidality in the past month
4. and severe non-opioid substance use disorder in the past year as assessed with the MINI
5. clinically unstable illness judged to interfere with treatment, and presence of facial/jaw pain
6. pregnancy
7. inability or unwillingness of individual to give written informed consent
8. physical characteristics that preclude neuroimaging or study procedures (e.g., metal implants, etc.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Support Group	Support Group	Participants will attend a support group weekly for eight weeks.
Mindfulness-Oriented Recovery Enhancement	Mindfulness-Oriented Recovery Enhancement (MORE)	Participants will attend a Mindfulness-Oriented Recovery Enhancement (MORE) group weekly for eight weeks.

Primary Outcome Measures

Name	Time	Method
Changes in fMRI activity level during natural reward processing	Change from week 0 to 8 weeks	Blood oxygen dependent signal (BOLD) response during viewing and regulating response to natural reward cues measured during a fMRI scan.
Changes in endogenous opioid system function in response to pain challenge	Change from week 0 to 8 weeks	PET opioid receptor binding potential from baseline through pain challenge

Secondary Outcome Measures

Name	Time	Method
Pain sensitivity as a measure of volume of hypertonic saline	Change from week 0 to 8 weeks	Volume of hypertonic saline to maintain pain at 40 out of 100 on a VAS
Self-report affect ratings	Change from week 0 to 8 weeks
Significant correlation between PET and fMRI measures with improvements in clinical pain, affect, and opioid use	Change from week 0 to 8 weeks

Trial Locations

Locations (1)

College of Social Work; 🇺🇸 Salt Lake City, Utah, United States